Durell, Todd M <br/><br/>
Atomoxetine treatment of attention-deficit/hyperactivity disorder in young adults with assessment of functional outcomes: a randomized, double-blind, placebo-controlled clinical trial.  [electronic resource] 

 -  Journal of clinical psychopharmacology  Feb 2013 
 - 45-54 p.  digital 
<br/><br/> Publication Type: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1533-712X 
<br/><br/><label>Standard No.: </label>10.1097/JCP.0b013e31827d8a23  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adrenergic Uptake Inhibitors--adverse effects<br/>Adult<br/>Analysis of Variance<br/>Atomoxetine Hydrochloride<br/>Attention--drug effects<br/>Attention Deficit Disorder with Hyperactivity--diagnosis<br/>Double-Blind Method<br/>Executive Function--drug effects<br/>Humans<br/>Least-Squares Analysis<br/>Predictive Value of Tests<br/>Propylamines--adverse effects<br/>Prospective Studies<br/>Psychiatric Status Rating Scales<br/>Puerto Rico<br/>Quality of Life<br/>Recovery of Function<br/>Severity of Illness Index<br/>Time Factors<br/>Treatment Outcome<br/>United States<br/>Young Adult